SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Undertaking For Non-Applicability Of Large Corporate Criteria
We hereby confirm that we do not fall under the category of a Large Corporate criteria as per the applicability criteria given under the SEBI circular SEBl/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliance Certificate - Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
As per the requirements of Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find herewith the Compliance Certificate dated April 20, 2022 issued by M/s. Veenit Pal & Associates, Practicing Company Secretaries, for the year ended 31st March, 2022. This is for your information and records. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 19, 2022 for Shanghvi Finance Pvt Ltd SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Certificate from CEO/CFO
Please find attached the certificate issued by the Chief Financial Officer of the Company for the quarter ended March 31, 2022. Kindly note we have redeemed all the outstanding Commercial Papers in the quarter ended March 31, 2022. You are requested to take the same on record.
'Do not engage': Sun Pharma warns of fake website spreading rumour about free gift
Sun Pharma says, this is a fake website spreading false information that Sun Pharmaceutical Industries Ltd. is providing a 40th Anniversary Celebration Gift. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2022 SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sun Pharma introducing its version of Vortioxetine in India.